ARTICLE | Clinical News
Humira adalimumab: Phase III; marketed to treat rheumatoid arthritis (RA)
February 9, 2004 8:00 AM UTC
ABT began a placebo-controlled, international Phase III trial of Humira in ankylosing spondylitis patients who have inadequate responses to NSAIDs. Cambridge Antibody Technology Group plc (LSE:CAT; C...